|
[1]
|
Hermans LE, Moorhouse M, Carmona S, Grobbee DE, Hofstra LM, Richman DD, et al. Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study. Lancet Infect Dis 2018;18(2):188 − 97. https://doi.org/10.1016/S1473-3099(17)30681-3CrossRef
|
|
[2]
|
Bai RJ, Lv SY, Hua W, Su B, Wang S, Shao Y, et al. Factors associated with human immunodeficiency virus-1 low-level viremia and its impact on virological and immunological outcomes: a retrospective cohort study in Beijing, China. HIV Med 2022;23 Suppl 1:72-83. http://dx.doi.org/10.1111/hiv.13251. |
|
[3]
|
Elvstam O, Malmborn K, Elén S, Marrone G, García F, Zazzi M, et al. Virologic failure following low-level viremia and viral blips during antiretroviral therapy: results from a European multicenter cohort. Clin Infect Dis 2023;76(1):25 − 31. https://doi.org/10.1093/cid/ciac762CrossRef
|
|
[4]
|
Nanyeenya N, Chang LW, Kiwanuka N, Nasuuna E, Nakanjako D, Nakigozi G, et al. The association between low-level viraemia and subsequent viral non-suppression among people living with HIV/AIDS on antiretroviral therapy in Uganda. PLoS One 2023;18(1):e0279479. https://doi.org/10.1371/journal.pone.0279479CrossRef
|
|
[5]
|
Zhao S, Wang W, Li S, He J, Duan W, Fang Z, et al. The Prevalence of Low-level Viraemia and Its Association with Virological Failure in People Living With HIV: A Systematic Review and Meta-Analysis. Emerg Microbes Infect 2024;2447613. https://doi.org/10.1080/22221751.2024.2447613. |
|
[6]
|
Hou YY, Liu JY, Zhao Y, Wu YS, Ma Y, Zhao DC, et al. Epidemiological trends of severely immunosuppressed people living with HIV at time of starting antiretroviral treatment in China during 2005-2018. J Infect 2022;84(3):400 − 9. https://doi.org/10.1016/j.jinf.2021.12.034CrossRef
|
|
[7]
|
Yu HL, Yang YC, Cao DD, Zhao Y, Jin C, Sun HL, et al. Association of low‐level viremia with mortality among people living with HIV on antiretroviral therapy in Dehong, Southwest China: a retrospective cohort study. HIV Med 2023;24(1):37 − 45. https://doi.org/10.1111/hiv.13320CrossRef
|
|
[8]
|
An J, Lao YF, Tang SY, Lou JC, Li TS, Dong XQ. The impact of low-level viraemia on virological failure-results from a multicenter HIV antiretroviral therapy cohort study in Yunnan, China. Front Med 2022;9:939261. https://doi.org/10.3389/fmed.2022.939261CrossRef
|
|
[9]
|
Ding HB, Xu JJ, Liu J, Wang Q, Kang J, Li XL, et al. Outcomes of persistent low-level viremia among HIV patients on antiretroviral therapy: a prospective cohort study. HIV Med 2022;23 Suppl 1:64-71. http://dx.doi.org/10.1111/hiv.13250. |
|
[10]
|
Brattgård H, Björkman P, Nowak P, Treutiger CJ, Gisslén M, Elvstam O. Factors associated with low-level viraemia in people with HIV starting antiretroviral therapy: a Swedish observational study. PLoS One 2022;17(5):e0268540. https://doi.org/10.1371/journal.pone.0268540CrossRef
|